Transfer learning has demonstrated efficacy in single-property constraint molecular generation. However, real-world drug discovery demands molecules to satisfy multiple property constraints. Existing paradigms often struggle with this challenge due to catastrophic forgetting or gradient conflicts. To address this, we propose a conflict-aware molecular language model merging framework (CAML). CAML generates multiple constraints molecular as a cooperative game among property-specific fine-tune models (expert models). Specifically, we formulate a Stability-Aware Covariance Matrix Adaptation Evolution Strategy (SACMA-ES) to dynamically optimize the fusion strategy. This algorithm searches for a Nash-equilibrium–like solution that minimizes conflicts among properties by exploring the optimal combination of the importance of the task parameter (intrinsic scale) and relative fusion weights of each expert (fusion coefficient), yielding a multi-constraint molecular property generation model without revisiting the training data. Extensive experiments demonstrate that CAML achieves state-of-the-art performance in complex multi-constraint scenarios. Our results validate that this training-free paradigm offers a robust and efficient solution for resolving intrinsic property conflicts in de novo molecular design.

Drug repurposing plays a critical role in accelerating treatment discovery, especially for complex and rare diseases. Biomedical knowledge graphs (KGs), which encode rich clinical associations, have been widely adopted to support this task. However, existing methods largely overlook common-sense biomedical concept knowledge in real-world labs, such as mechanistic priors indicating that certain drugs are fundamentally incompatible with specific treatments. To address this gap, we propose LLaDR, a Large Language Model-assisted framework for Drug Repurposing, which improves the representation of biomedical concepts within KGs. Specifically, we extract semantically enriched treatment-related textual representations of biomedical entities from large language models (LLMs) and use them to fine-tune knowledge graph embedding (KGE) models. By injecting treatment-relevant knowledge into KGE, LLaDR largely improves the representation of biomedical concepts, enhancing semantic understanding of under-studied or complex indications. Experiments based on benchmarks demonstrate that LLaDR achieves state-of-the-art performance across different scenarios, with case studies on Alzheimer’s disease further confirming its robustness and effectiveness.